May 02, 2016 at 10:18 | Source: Moneycontrol.com
Bayer CropScience Ltd has informed BSE that a meeting of the Board of Directors of the Company held will be held on May 13, 2016, inter alia, to take on record the Audited Financial Results of the Company for the year ended March 31, 2016 and to consider recommendation of final dividend, if any.
Apr 14, 2016 at 14:50 | Source: PTI
According to a report by Prime Database, 15 buyback offers were concluded last fiscal with a total acquired sum of Rs 1,713 crore, while the amount on offer was Rs 1,763 crore.
Apr 13, 2016 at 19:35 | Source: CNBC-TV18
Jyotivardhan Jaipuria Founder & MD Veda Investment Managers says that stable sectors like IT and pharmaceutical are likely to report lower double-digit growth going forward.
Apr 12, 2016 at 21:40 | Source: CNBC-TV18
In an interview with CNBC-TV18, market expert SP Tulsian gave his stock picks and shared his outlook for the market going forward.
Mar 14, 2016 at 19:22 | Source: PTI
Mallya recently resigned as chairman and director of United Spirits. He, however, remains on board of various other companies, including those from his UB Group as also a few others, including Indian subsidiaries of some multinational companies.
Mar 04, 2016 at 12:43 | Source: Moneycontrol.com
Bayer CropScience Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 04, 2016, has appointed Mr. Ulrich Stefer as an Additional Director of the Company with effect from March 04, 2016.
Feb 25, 2016 at 12:44 | Source: Moneycontrol.com
Bayer CropScience Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on March 04, 2016, inter alia, to consider and approve the appointment of an Additional Director on the Board of the Company.
Feb 17, 2016 at 09:22 | Source: Moneycontrol.com
Glenmark Pharmaceuticals Inc., USA has been granted tentative approval by the United States Food & Drug Administration (USFDA) for its Azelaic Acid Gel, 15 percent, the generic version of Finacea Topical Gel, 15 percent of Bayer Healthcare.
Feb 12, 2016 at 17:07 | Source: Moneycontrol.com
EIS is bearish on Bayer CropScience has recommended Sell rating on the stock with a target price of Rs 2302 in its research report dated February 3, 2016.
Feb 03, 2016 at 09:51 | Source: Moneycontrol.com
Bayer CropScience has reported a sales total income from operations of Rs 642.40 crore and a net profit of Rs 27.40 crore for the quarter ended Dec '15